Services > Feed-O-Matic > 160534 šŸ”—

Tuesday 26 October 2021 12:10

Italy likely to offer third dose of covid vaccine to all from January

Covid vaccines to be extended toĀ children in Italy as soon as regulatory authorities give the green light, says Sileri.Italy is likely to start offering a third dose of the covid vaccine to the general population starting from January 2022, the country's deputy health minister Pierpaolo SileriĀ said on Tuesday.Currently the third dose or "booster jab" is offered to the most vulnerable in society, such as cancer patients and transplant recipients, as well as the elderly and medical workers. "The third dose will probably be necessary for everyone," Sileri told Radio Capital, adding that the vaccinations would be programmed based on when people received their last jab, with priority given to those who had the single-dose Johnson&Johnson vaccine. Italy to start giving third dose of covid vaccine "We will get rid of the mandatory Green Pass, but not now. We have to proceed step by step" - the health undersecretary said - "First we will remove the obligation of social distancing, then the masks and finally the Green Pass." Italy may revise covid Green Pass in 2022, says deputy health minister Sileri also said that covid vaccines would become available in Italy for children aged five to 11 as soon as the move is approved by regulatory authorities. "I have a two-year-old son and if there were a vaccine available for his age I would give it to him immediately. Unfortunately, there isn't yet," Sileri said. Italy's vaccination campaign Just overĀ 86 per cent of the Italian population above the age of 12 has had at least one dose of the covid vaccine, while 82 per cent are fully vaccinated, according to the latest data. Last week Italian premier Mario Draghi said that Italy's vaccination campaign is moving faster than the EU average. For official informationĀ about the covid-19 situation in Italy - in English - see theĀ health ministry website.Ā Details about the Green Pass can be found - in Italian - on theĀ Certificazione Verde website. Photo credit: MikeDotta / Shutterstock.com.

read the news on Wanted in Rome - Rome's local English news



Italy is likely to start offering a third dose of the covid vaccine to the general population starting from January 2022, the country's deputy health minister
Pierpaolo Sileri
Ā said on Tuesday. Currently the third dose or "booster jab" is offered to the most vulnerable in society, such as cancer patients and transplant recipients, as well as the elderly and medical workers. "The third dose will probably be necessary for everyone," Sileri told Radio Capital, adding that the vaccinations would be programmed based on when people received their last jab, with priority given to those who had the single-dose Johnson&Johnson vaccine.
  • Italy to start giving third dose of covid vaccine
"We will get rid of the mandatory
Green Pass
, but not now. We have to proceed step by step" - the health undersecretary said - "First we will remove the obligation of social distancing, then the masks and finally the Green Pass."
  • Italy may revise covid Green Pass in 2022, says deputy health minister
Sileri also said that covid vaccines would become available in Italy for children aged five to 11 as soon as the move is approved by regulatory authorities. "I have a two-year-old son and if there were a vaccine available for his age I would give it to him immediately. Unfortunately, there isn't yet," Sileri said. Just overĀ 86 per cent of the Italian population above the age of 12 has had at least one dose of the covid vaccine, while 82 per cent are fully vaccinated, according to the
latest data
. Last week Italian premier Mario Draghi said that Italy's vaccination campaign is
moving faster
than the EU average. For official informationĀ about the covid-19 situation in Italy - in English - see theĀ 
health ministry website
.Ā Details about the Green Pass can be found - in Italian - on theĀ 
Certificazione Verde website
. Photo credit: MikeDotta / Shutterstock.com.
most readead
This site uses technical cookies, including from third parties, to improve the services offered and optimize the user experience. Please read the privacy policy. By closing this banner you accept the privacy conditions and consent to the use of cookies.
CLOSE